Literature DB >> 18283398

Radiosurgery of brain arteriovenous malformations in children.

D R Buis1, C M F Dirven, F J Lagerwaard, E S Mandl, G J Lycklama A Nijeholt, D S Eshghi, R van den Berg, J C Baayen, O W M Meijer, B J Slotman, W P Vandertop.   

Abstract

OBJECTIVE: The authors describe their experience in treating 22 children with a single brain arteriovenous malformation (bAVM) using a dedicated LINAC stereotactic radiosurgery unit.
METHODS: The findings of 22 consecutive patients < or = 18 years of age who underwent radiosurgery for a single bAVM and with at least 24 months of follow-up, or earlier proven obliteration,were reviewed. The median age at radiosurgery was 13.8 years,with a hemorrhagic presentation in 86%. Median bAVM-volume was 1.8 ml, with a median prescribed marginal dose of 19.0 Gy.
RESULTS: The crude complete obliteration-rate was 68% (n = 15) after a median follow-up of 24 months. The actuarial obliteration- rate was 45 % after two years and 64 % after three years. Patients with a radiosurgery-based AVM score < or = 1 more frequently had an excellent outcome than patients with a bAVM score > 1 (71% vs. 20%, P = 0.12), as well as an increased obliteration rate (P = 0.03) One patient died from a bAVM-related hemorrhage 27 months after radiosurgery, representing a postradiosurgery hemorrhage rate of 1.3%/year for the complete followup interval. Overall outcome was good to excellent in 68% (n = 15). Radiation-induced changes on MR imaging were seen in 36% (n = 8) after a median interval of 12.5 months, resulting in deterioration of pre-existing neurological symptoms in one patient.
CONCLUSIONS: Radiosurgery is a relatively effective, minimally invasive treatment for small bAVMs in children. The rebleeding rate is low, provided that known predilection places for bleeding had been endovascularly eliminated.Our overall results compare unfavourably to recent pediatric microsurgical series, although comparison between series remains imprecise. Nevertheless, when treatment is indicated in a child with a bAVM that is amenable to both microsurgery or radiosurgery, microsurgery should carefully be advocated over radiosurgery, because of its immediate risk reduction.

Entities:  

Mesh:

Year:  2008        PMID: 18283398     DOI: 10.1007/s00415-008-0739-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  43 in total

1.  Recurrence in a different location of a cerebral arteriovenous malformation in a child after radiosurgery.

Authors:  C Rodríguez-Arias; R Martínez; G Rey; G Bravo
Journal:  Childs Nerv Syst       Date:  2000-06       Impact factor: 1.475

2.  Comparison between adult and pediatric arteriovenous malformations treated by Gamma Knife radiosurgery.

Authors:  T Tanaka; T Kobayashi; Y Kida; H Oyama; M Niwa
Journal:  Stereotact Funct Neurosurg       Date:  1996       Impact factor: 1.875

3.  Seizure outcome in children treated for arteriovenous malformations using gamma knife radiosurgery.

Authors:  P C Gerszten; P D Adelson; D Kondziolka; J C Flickinger; L D Lunsford
Journal:  Pediatr Neurosurg       Date:  1996       Impact factor: 1.162

4.  Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations.

Authors:  Heather J Fullerton; Achal S Achrol; S Claiborne Johnston; Charles E McCulloch; Randall T Higashida; Michael T Lawton; Stephen Sidney; William L Young
Journal:  Stroke       Date:  2005-09-01       Impact factor: 7.914

5.  Long-term complications after gamma knife surgery for arteriovenous malformations.

Authors:  Masahiro Izawa; Motohiro Hayashi; Mikhail Chernov; Koutarou Nakaya; Taku Ochiai; Noriko Murata; Yuchii Takasu; Osami Kubo; Tomokatsu Hori; Kintomo Takakura
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

6.  A proposed radiosurgery-based grading system for arteriovenous malformations.

Authors:  Bruce E Pollock; John C Flickinger
Journal:  J Neurosurg       Date:  2002-01       Impact factor: 5.115

7.  Intensity-modulated radiosurgery for childhood arteriovenous malformations.

Authors:  M Fuss; B J Salter; J-L Caron; D G Vollmer; T S Herman
Journal:  Acta Neurochir (Wien)       Date:  2005-11       Impact factor: 2.216

8.  Angiographic long-term follow-up data for arteriovenous malformations previously proven to be obliterated after gamma knife radiosurgery.

Authors:  M Lindqvist; B Karlsson; W Y Guo; L Kihlström; B Lippitz; M Yamamoto
Journal:  Neurosurgery       Date:  2000-04       Impact factor: 4.654

9.  Treatment of arteriovenous malformations with stereotactic radiosurgery employing both magnetic resonance angiography and standard angiography as a database.

Authors:  D Petereit; M Mehta; P Turski; A Levin; C Strother; C Mistretta; R Mackie; M Gehring; S Kubsad; T Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1993-01-15       Impact factor: 7.038

Review 10.  Interventions for treating brain arteriovenous malformations in adults.

Authors:  R Al-Shahi; C P Warlow
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25
View more
  11 in total

1.  The predictive value of 3D time-of-flight MR angiography in assessment of brain arteriovenous malformation obliteration after radiosurgery.

Authors:  D R Buis; J C J Bot; F Barkhof; D L Knol; F J Lagerwaard; B J Slotman; W P Vandertop; R van den Berg
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-17       Impact factor: 3.825

2.  Clinico-radiological outcomes following gamma knife radiosurgery for pediatric arteriovenous malformations.

Authors:  Je Young Yeon; Hyung Jin Shin; Jong-Soo Kim; Seung-Chyul Hong; Jung-Il Lee
Journal:  Childs Nerv Syst       Date:  2011-02-01       Impact factor: 1.475

3.  Clinical outcomes and radiosurgical considerations for pediatric arteriovenous malformation: influence of clinical features on obliteration rate.

Authors:  Chang Kyu Park; Seok Keun Choi; Sung Ho Lee; Man Kyu Choi; Young Jin Lim
Journal:  Childs Nerv Syst       Date:  2017-09-04       Impact factor: 1.475

4.  Safety and efficacy using a detachable tip microcatheter in the embolization of pediatric arteriovenous malformations.

Authors:  David Altschul; Srinivasan Paramasivam; Santiago Ortega-Gutierrez; Johanna T Fifi; Alejandro Berenstein
Journal:  Childs Nerv Syst       Date:  2014-03-27       Impact factor: 1.475

5.  Stereotactic radiotherapy and radiosurgery in pediatric patients: analysis of indications and outcome.

Authors:  Bilal Mirza; Anne Mønsted; Josephine Harding; Lars Ohlhues; Henrik Roed; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2010-07-29       Impact factor: 1.475

6.  Pediatric Intracranial Arteriovenous Malformation: Long-Term Outcomes with Linear Accelerator (LINAC)-Based Radiosurgery.

Authors:  Ethan M Glazener; Kenneth Lodin; Michael J Miller; Matthew J Frager; Javad Rahimian; Joseph C T Chen; Michael R Girvigian
Journal:  Adv Radiat Oncol       Date:  2020-04-13

7.  Angiographic features help predict outcome after stereotactic radiosurgery for the treatment of pediatric arteriovenous malformations.

Authors:  Sunil A Sheth; Matthew B Potts; Penny K Sneed; William L Young; Daniel L Cooke; Nalin Gupta; Steven W Hetts
Journal:  Childs Nerv Syst       Date:  2013-07-27       Impact factor: 1.475

8.  Gamma Knife radiosurgery for arteriovenous malformations in pediatric patients.

Authors:  Alp Özgün Börcek; Hakan Emmez; Koray M Akkan; Özgür Öcal; Gökhan Kurt; Sükrü Aykol; Eray Karahacioğli; Kemali M Baykaner
Journal:  Childs Nerv Syst       Date:  2014-06-28       Impact factor: 1.475

9.  Stereotactic linac radiosurgery and hypofractionated stereotactic radiotherapy for pediatric arteriovenous malformations of the brain: experiences of a single institution.

Authors:  Sławomir Blamek; Dawid Larysz; Leszek Miszczyk
Journal:  Childs Nerv Syst       Date:  2012-12-08       Impact factor: 1.475

10.  Comparison of the Long-term Efficacy and Safety of Gamma Knife Radiosurgery for Arteriovenous Malformations in Pediatric and Adult Patients.

Authors:  Hirotaka Hasegawa; Shunya Hanakita; Masahiro Shin; Mariko Kawashima; Wataru Takahashi; Osamu Ishikawa; Satoshi Koizumi; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-05-17       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.